1800-1915
Rewley House, 1 Wellington Square, Oxford OX1 2JA
Clinical Research Fellow Kenneth Chan will explain how Caristo Diagnostics’ CaRi-Heart® device combines CT scans with artificial intelligence (AI) to predict heart attack risk in patients with suspected coronary artery disease. Health Innovation Oxford and Thames Valley carried out a feasibility study, interviewing clinical stakeholders to investigate the potential clinical utility, benefits and barriers to adopting CaRi-Heart® into the NHS care pathway for chest pain assessment. Read more in our CaRi-Heart® case study.
Further information about this free talk which is hosted by the NIHR Oxford Biomedical Research Centre. No booking required.